University Hospital Monklands is a district general hospital in Airdrie, North Lanarkshire, Scotland. It serves a population of approximately 260,000 people of North and South Lanarkshire council areas and is managed by NHS Lanarkshire.

There are 535 beds in Monklands Hospital.

During the past decade, Monklands Hospital conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 5 clinical trials were completed, i.e. on average, 45.5% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Monklands Hospital" #1 sponsor was "LEO Pharma" with 3 trials, followed by "University of Glasgow" with 3 trials sponsored, "University College, London" with 2 trials sponsored, "University Hospital Southampton NHS Foundation Trust" with 2 trials sponsored and "Boehringer Ingelheim" with 2 trials sponsored. Other sponsors include 12 different institutions and companies that sponsored additional 22 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Monklands Hospital" #1 collaborator was "Cancer Research UK" with 4 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator, "British Heart Foundation" with 1 trials as a collaborator and "British Kidney Patients Association" with 1 trials as a collaborator. Other collaborators include 8 different institutions and companies that were collaborators in the rest 18 trials.

According to Clinical.Site data, the most researched conditions in "Monklands Hospital" are "Lymphoma" (5 trials), "Leukemia" (3 trials), "Diffuse Large B Cell Lymphoma" (2 trials), "Accelerated Phase Chronic Myelogenous Leukemia" (1 trials) and "Actinic Keratosis (AK)" (1 trials). Many other conditions were trialed in "Monklands Hospital" in a lesser frequency.

Most popular intervention types in "Monklands Hospital" are "Drug" (22 trials), "Biological" (6 trials), "Other" (4 trials), "Procedure" (3 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "fludarabine phosphate" (4 trials), "cyclophosphamide" (3 trials), "rituximab" (3 trials), "bleomycin sulfate" (2 trials) and "chlorambucil" (2 trials). Other intervention names were less common.

The vast majority of trials in "Monklands Hospital" are 28 trials for "All" genders.

Currently, there are NaN active trials in "Monklands Hospital". undefined are not yet recruiting, 4 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 18 completed trials in Monklands Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Monklands Hospital, 1 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 2 trials that are defined as “Not Applicable".